A carregar...

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

BACKGROUND: As one of the many breast cancer subtypes, human epidermal growth factor receptor 2 (Her2)-positive breast cancer has higher invasiveness and poor prognosis, although the advent of anti-Her2 drugs has brought good news to patients. However, the emergence of drug resistance still limits i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Gao, Chundi, Zhuang, Jing, Li, Huayao, Liu, Cun, Zhou, Chao, Liu, Lijuan, Feng, Fubin, Sun, Changgang, Wu, Jibiao
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161270/
https://ncbi.nlm.nih.gov/pubmed/32322168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01175-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!